Quality control of the primary cilium proteome
初级纤毛蛋白质组的质量控制
基本信息
- 批准号:10546935
- 负责人:
- 金额:$ 5.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-01 至 2024-01-31
- 项目状态:已结题
- 来源:
- 关键词:AppearanceBardet-Biedl SyndromeBindingBiological AssayCell membraneCellsCiliaComplexCoupledCuesCystic kidneyDataDevelopmentDiffuseDiffusionDiseaseEndocytosisEndosomesErinaceidaeEtiologyEventExcisionFunctional disorderFundingG-Protein-Coupled ReceptorsGoalsHairHealthHereditary DiseaseHomeostasisHumanInvestigationKnowledgeLateralLeadLigaseLightLinkMembrane ProteinsModelingMolecularMovementMyosin ATPaseObesityPathway interactionsPolydactylyProteinsProteomeProteomicsQuality ControlReaderReceptor SignalingRegulationResearchRestRetinal DegenerationRoleSSTR3 geneSignal PathwaySignal TransductionSmell PerceptionSorting - Cell MovementStructureTestingTherapeutic InterventionUbiquitinUbiquitinationVariantVisionWorkbasehedgehog signal transductionkidney malformationmolecular imagingmutantnovelprogramsprotein complexrecruitsensorsensory inputsingle moleculeskeletal abnormalitysmoothened signaling pathwaytraffickingubiquitin ligase
项目摘要
PROJECT SUMMARY
Primary cilia organize signaling pathways such as vision, olfaction and Hedgehog signaling. The
movements of signaling receptors into, inside and out of cilium are critical for the correct regulation of these
pathways, yet our understanding of the basic mechanisms governing signaling receptor trafficking through cilia
remains fragmentary. Past work from the lab identified and characterized the BBSome, a protein complex that
ferries signaling receptors out of cilia. The relevance of the BBSome to human health and disease is evidence
by the fact that BBSome dysfunction causes Bardet-Biedl Syndrome (BBS), a hereditary disease characterized
by obesity, retinal degeneration, polydactyly and kidney malformations.
The major goal of this proposal is to determine how the BBSome selects signaling receptors for removal
from cilia. The emphasis in this funding period will be on investigating the role of ubiquitin in tagging membrane
proteins for removal from cilia. Preliminary data indicate the existence of a ciliary machinery that recognizes
activated GPCRs, ubiquitinates them and sorts ubiquitinated GPCRs out of cilia. We will characterize the
molecules acting at each of these steps using quantitative assays for signal-dependent GPCR exit. The
hierarchical ordering of the molecular cogs and levers that affix and read ubiquitin on proteins that need to exit
cilia promises to uncover a multi-step pathway reminiscent of the ESCRT machinery responsible for
degradative sorting. Finally, the fate of GPCRs that exit cilia will be tracked by single-molecule imaging to
determine whether endocytosis is coupled to ciliary exit or whether GPCRs instead diffuse into the plasma
membrane after exiting cilia.
The proposed studies will cast new light on how the ciliary abundance of proteins is regulated and open the
door to a mechanistic investigation of ciliary quality control.
项目摘要
初级纤毛组织信号通路,如视觉,嗅觉和刺猬信号。的
信号受体进入纤毛、进入纤毛和离开纤毛的运动对于正确调节这些信号受体是至关重要的。
途径,但我们的理解的基本机制,通过纤毛信号受体贩运
仍然支离破碎。实验室过去的工作鉴定并表征了BBSome,这是一种蛋白质复合物,
将信号受体从纤毛中运送出来。BBSome与人类健康和疾病的相关性是证据
BBSome功能障碍导致Bardet-Biedl综合征(BBS),这是一种遗传性疾病,
肥胖、视网膜退化、多指畸形和肾脏畸形。
该提案的主要目标是确定BBSome如何选择信号受体进行移除
cilia的。在这一资助期间的重点将是调查泛素在标记膜的作用,
去除纤毛的蛋白质。初步数据表明存在一种纤毛机制,
激活GPCR,使它们泛素化,并将泛素化的GPCR从纤毛中分离出来。我们将描述
分子在这些步骤中的每一个使用信号依赖性GPCR退出的定量测定。的
分子齿轮和杠杆的等级排序,这些齿轮和杠杆在需要退出的蛋白质上附着和读取泛素
纤毛有望揭示一个多步骤的途径,让人想起ESCRT机制,
退化排序最后,将通过单分子成像跟踪退出纤毛的GPCR的命运,
确定内吞作用是否与纤毛出口偶联,或者GPCR是否反而扩散到血浆中
离开纤毛后的膜。
这项研究将为纤毛蛋白质丰度的调节提供新的思路,并打开纤毛蛋白质的表达途径。
一个门的睫状体质量控制的机制调查。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Maxence V Nachury其他文献
Xenopus Cdc14α/β are localized to the nucleolus and centrosome and are required for embryonic cell division
- DOI:
10.1186/1471-2121-5-27 - 发表时间:
2004-07-13 - 期刊:
- 影响因子:2.700
- 作者:
Brett K Kaiser;Maxence V Nachury;Bryan E Gardner;Peter K Jackson - 通讯作者:
Peter K Jackson
Maxence V Nachury的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Maxence V Nachury', 18)}}的其他基金
Structural basis of BBSome-mediated ciliary exit
BBSome介导的纤毛退出的结构基础
- 批准号:
10161785 - 财政年份:2020
- 资助金额:
$ 5.35万 - 项目类别:
Structural basis of BBSome-mediated ciliary exit
BBSome介导的纤毛退出的结构基础
- 批准号:
10409687 - 财政年份:2020
- 资助金额:
$ 5.35万 - 项目类别:
Structural basis of BBSome-mediated ciliary exit
BBSome介导的纤毛退出的结构基础
- 批准号:
10624912 - 财政年份:2020
- 资助金额:
$ 5.35万 - 项目类别:
Proteomics of Primary Cilia through Proximity Labeling
通过邻近标记研究初级纤毛的蛋白质组学
- 批准号:
9590675 - 财政年份:2015
- 资助金额:
$ 5.35万 - 项目类别:
相似海外基金
Using a patient-derived fibroblast ciliation assay to perform high throughput drug screen and candidate therapeutic compound validation for Bardet-Biedl syndrome (BBS)
使用患者来源的成纤维细胞纤毛检测对 Bardet-Biedl 综合征 (BBS) 进行高通量药物筛选和候选治疗化合物验证
- 批准号:
449358 - 财政年份:2020
- 资助金额:
$ 5.35万 - 项目类别:
Studentship Programs
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
- 批准号:
8918625 - 财政年份:2012
- 资助金额:
$ 5.35万 - 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
- 批准号:
8534137 - 财政年份:2012
- 资助金额:
$ 5.35万 - 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
- 批准号:
8340877 - 财政年份:2012
- 资助金额:
$ 5.35万 - 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
- 批准号:
8708874 - 财政年份:2012
- 资助金额:
$ 5.35万 - 项目类别:
Molecular Pathophysiology of Retinal Degeneration in Bardet-Biedl Syndrome
Bardet-Biedl 综合征视网膜变性的分子病理生理学
- 批准号:
9235611 - 财政年份:2012
- 资助金额:
$ 5.35万 - 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
- 批准号:
8146164 - 财政年份:2009
- 资助金额:
$ 5.35万 - 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
- 批准号:
7753399 - 财政年份:2009
- 资助金额:
$ 5.35万 - 项目类别:
Towards a structural understanding of childhood obesity in Bardet-Biedl syndrome
对 Bardet-Biedl 综合征儿童肥胖的结构性理解
- 批准号:
7938614 - 财政年份:2009
- 资助金额:
$ 5.35万 - 项目类别:
Small GTPase ARL6 segregates with Bardet-Biedl Syndrome 3 (BBS3) and may be required for cell cycle progession
小 GTP 酶 ARL6 与 Bardet-Biedl 综合征 3 (BBS3) 分离,并且可能是细胞周期进展所必需的
- 批准号:
361511-2008 - 财政年份:2008
- 资助金额:
$ 5.35万 - 项目类别:
Alexander Graham Bell Canada Graduate Scholarships - Master's